Novantrone
Showing 26 - 50 of 73
Prostate Cancer Trial in Houston (Mitoxantrone (Novantrone), Bortezomib (PS-341))
Completed
- Prostate Cancer
- Mitoxantrone (Novantrone)
- Bortezomib (PS-341)
-
Houston, TexasUniversity of Texas MD Anderson Cancer Center
Nov 14, 2018
Acute Lymphoblastic Leukemia, Lymphoma, Non-Hodgkin's, Leukemia, T-Cell Trial in Memphis (Dexamethasone, Panobinostat, Liposomal
Terminated
- Acute Lymphoblastic Leukemia
- +3 more
- Dexamethasone
- +13 more
-
Memphis, TennesseeSt. Jude Children's Research Hospital
Mar 8, 2019
Acute Myeloid Leukemia, Down Syndrome, Myelodysplastic Syndrome Trial in Worldwide (Asparaginase, Asparaginase Erwinia
Active, not recruiting
- Acute Myeloid Leukemia
- +4 more
- Asparaginase
- +7 more
-
Birmingham, Alabama
- +190 more
Jan 30, 2023
Recurrent Adult Acute Myeloid Leukemia, Refractory Acute Myeloid Leukemia Trial in Cleveland (ixazomib, mitoxantrone HCl,
Completed
- Recurrent Adult Acute Myeloid Leukemia
- Refractory Acute Myeloid Leukemia
- ixazomib
- +3 more
-
Cleveland, Ohio
- +1 more
Dec 12, 2018
Lymphoma Trial in Houston (biological, drug, procedure, radiation)
Completed
- Lymphoma
- Bleomycin Sulfate (BLM)
- +17 more
-
Houston, TexasUniversity of Texas - MD Anderson Cancer Center
Nov 13, 2018
Acute Myeloid Leukemia Trial in Canada, Puerto Rico, United States (procedure, drug, behavioral)
Recruiting
- Acute Myeloid Leukemia
- Allogeneic Hematopoietic Stem Cell Transplantation
- +13 more
-
Birmingham, Alabama
- +187 more
Apr 28, 2022
Previously Treated Myelodysplastic Syndrome, Recurrent Adult Acute Myeloid Leukemia Trial in Kennewick, Kirkland, Seattle
Completed
- Previously Treated Myelodysplastic Syndrome
- Recurrent Adult Acute Myeloid Leukemia
- Cytarabine
- +4 more
-
Kennewick, Washington
- +2 more
Feb 5, 2019
Adult Acute Megakaryoblastic Leukemia (M7), Adult Acute Minimally Differentiated Myeloid Leukemia (M0), Adult Acute Monoblastic
Terminated
- Adult Acute Megakaryoblastic Leukemia (M7)
- +14 more
- lenalidomide
- +3 more
-
Stanford, CaliforniaStanford University, School of Medicine
Oct 25, 2018
Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities, Adult Acute Myeloid Leukemia With Del(5q), Adult Acute Myeloid
Completed
- Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities
- +6 more
- CPI-613
- +4 more
-
Winston-Salem, North CarolinaComprehensive Cancer Center of Wake Forest University
Jun 29, 2018
Prostatic Tumors Trial in Stanford (Mitoxantrone, GM-CSF)
Terminated
- Prostatic Neoplasms
-
Stanford, CaliforniaStanford University School of Medicine
Oct 23, 2017
Acute Myeloid Leukemia With Multilineage Dysplasia Following Myelodysplastic Syndrome, Adult Acute Megakaryoblastic Leukemia
Completed
- Acute Myeloid Leukemia With Multilineage Dysplasia Following Myelodysplastic Syndrome
- +16 more
- alvocidib
- +4 more
-
Baltimore, Maryland
- +1 more
Aug 3, 2018
Adenocarcinoma of the Prostate, Recurrent Prostate Cancer, Stage IV Prostate Cancer Trial in San Francisco, Madison
Completed
- Adenocarcinoma of the Prostate
- +2 more
- mitoxantrone hydrochloride
- +2 more
-
San Francisco, California
- +1 more
Oct 2, 2017
Metastatic Castration-resistant Prostate Cancer Trial in Scottsdale, San Francisco, Nashville (Cabazitaxel, Mitoxantrone,
Completed
- Metastatic Castration-resistant Prostate Cancer
- Cabazitaxel
- +3 more
-
Scottsdale, Arizona
- +2 more
Jul 20, 2017
Recurrent Adult Acute Myeloid Leukemia, Refractory Acute Myeloid Leukemia Trial in Columbus (Azacitidine, Cytarabine, Etoposide
Completed
- Recurrent Adult Acute Myeloid Leukemia
- Refractory Acute Myeloid Leukemia
- Azacitidine
- +5 more
-
Columbus, OhioOhio State University Comprehensive Cancer Center
Sep 20, 2017
Leukemia, Myeloid, Acute Trial in Boston, St. Louis, Houston (G-CSF, Plerixafor, Mitoxantrone)
Relapsed or Refractory Mantle Cell Lymphoma (MCL) Trial (gemcitabine, mitoxantrone, rituximab)
Completed
- Relapsed or Refractory Mantle Cell Lymphoma (MCL)
- gemcitabine
- +2 more
- (no location specified)
Sep 15, 2016
Adenocarcinoma of the Prostate, Recurrent Prostate Cancer, Stage IV Prostate Cancer Trial in San Francisco (ixabepilone,
Completed
- Adenocarcinoma of the Prostate
- +2 more
- ixabepilone
- +2 more
-
San Francisco, CaliforniaUCSF Helen Diller Family Comprehensive Cancer Center
Feb 21, 2017
Adult Acute Megakaryoblastic Leukemia (M7), Adult Acute Minimally Differentiated Myeloid Leukemia (M0), Adult Acute Monoblastic
Terminated
- Adult Acute Megakaryoblastic Leukemia (M7)
- +14 more
- cyclosporine
- +4 more
-
Seattle, WashingtonFred Hutchinson Cancer Research Center/University of Washington
Jun 27, 2017
Leukemia, Myeloid, Acute Trial in St. Louis (AMD3100, Mitoxantrone, Etoposide)
Completed
- Leukemia, Myeloid, Acute
- AMD3100
- +3 more
-
St. Louis, MissouriWashington University
Oct 27, 2016
Androgen-independent Prostate Cancer Trial in United States (cetuximab, Mitoxantrone)
Completed
- Androgen-independent Prostate Cancer
-
Phoenix, Arizona
- +54 more
Oct 13, 2016
Prostatic Tumors Trial in Houston (GM-CSF, Ketoconazole, Mitoxantrone)
Terminated
- Prostatic Neoplasms
- GM-CSF
- +2 more
-
Houston, TexasBaylor College of Medicine - Methodist Hospital
Mar 15, 2016
Lymphoma Trial in Germany, United Kingdom (bleomycin sulfate, cyclophosphamide, etoposide)
Completed
- Lymphoma
- bleomycin sulfate
- +6 more
-
Cologne, Germany
- +53 more
Mar 29, 2017